IPP Bureau

3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing
3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing

By IPP Bureau - October 29, 2021

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Finvasia acquires Gini Health as it moves into healthcare tech
Finvasia acquires Gini Health as it moves into healthcare tech

By IPP Bureau - October 29, 2021

Gini Health works in the domain of personalised healthcare

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

By IPP Bureau - October 29, 2021

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke
Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

By IPP Bureau - October 29, 2021

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology

Indian Pharma Market witnesses rise in volumes and prices in September.
Indian Pharma Market witnesses rise in volumes and prices in September.

By IPP Bureau - October 28, 2021

Acute therapies continue to report strong growth compared to chronic ones.

KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals
KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals

By IPP Bureau - October 28, 2021

The combined entity will have 12 hospitals with 3,666 beds

MSD and MPP sign licensing agreement to make molnupiravir affordable
MSD and MPP sign licensing agreement to make molnupiravir affordable

By IPP Bureau - October 28, 2021

In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.

Ocugen submits IND application with U.S. FDA for Covaxin phase 3 trial
Ocugen submits IND application with U.S. FDA for Covaxin phase 3 trial

By IPP Bureau - October 28, 2021

The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population

Novartis receives priority review by U.S. FDA and filing acceptance by EMA for Kymriah
Novartis receives priority review by U.S. FDA and filing acceptance by EMA for Kymriah

By IPP Bureau - October 28, 2021

Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications

Rainbow hospital gives new lease of life to infant on ECMO support
Rainbow hospital gives new lease of life to infant on ECMO support

By IPP Bureau - October 28, 2021

The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease

AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses
AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses

By IPP Bureau - October 28, 2021

This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one

Oasis Fertility forays into Karnataka plans 10 more centres
Oasis Fertility forays into Karnataka plans 10 more centres

By IPP Bureau - October 28, 2021

It plans to double its network to 50 centres across India in the next three years

Thermo Fisher Scientific unveils Q Digital PCR system
Thermo Fisher Scientific unveils Q Digital PCR system

By IPP Bureau - October 28, 2021

It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development

Honeywell launches real-time health monitoring system
Honeywell launches real-time health monitoring system

By IPP Bureau - October 28, 2021

Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent

D2C pet care brand Wiggles.in raises US $ 5.5 million in its Pre-Series A round
D2C pet care brand Wiggles.in raises US $ 5.5 million in its Pre-Series A round

By IPP Bureau - October 28, 2021

This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem

Latest Stories

Interviews

Packaging